Atai Life Sciences Announces $130 Million Public Share Offering

New York, Friday, 17 October 2025.
Atai Life Sciences is launching a $130 million public share offering to fund its mental health drug development pipeline, including treatments for depression and anxiety, with Jefferies LLC as the lead bookrunner.